老年糖尿病医防融合的研究进展

doi:10.3969/j.issn.1003-9198.2023.07.004

摘要/Abstract

中图分类号:

王逸飞, 李铭麟, 张飞, 王佳贺. 老年糖尿病医防融合的研究进展[J]. 实用老年医学, 2023, 37(7): 658-661.

[1] 王欣荣, 李强翔, 杨芳. 老年糖尿病管理标准的研究进展 [J]. 中国临床保健杂志, 2023, 26(1): 135-139.
[2] CHO N H, SHAW J E, KARURANGA S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045 [J]. Diabetes Res Clin Pract, 2018, 138: 271-281.
[3] XU Y, WANG L, HE J, et al. Prevalence and control of diabetes in Chinese adults [J]. JAMA, 2013, 310(9): 948-959.
[4] 张晓琳, 刘珉, 李钢, 等. 不同管理模式对2型糖尿病患者血糖控制达标率的影响 [J]. 中国医药导报, 2019, 16(3): 53-56,70.
[5] DIXON D L, CARBONE S. Screening, identification, and management of prediabetes to reduce cardiovascular risk: a missed opportunity? [J]. Diabetes Metab Res Rev, 2020, 36(6): e3316.
[6] WANG J, SHEN X, HE S, et al. Hypertriglyceridaemia predicts subsequent long-term risk of cardiovascular events in Chinese adults: 23-year follow-up of the Daqing Diabetes Study [J]. Diabetes Metab Res Rev, 2019, 35(6): e3163.
[7] 《中国老年2型糖尿病防治临床指南》编写组. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中国糖尿病杂志, 2022, 30(1): 2-51.
[8] HAW J S, GALAVIZ K I, STRAUS A N, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials [J]. JAMA Intern Med, 2017, 177(12): 1808-1817.
[9] 潘琦, 郭立新. 《中国老年糖尿病诊疗指南(2021年版)》要览 [J]. 中国医学前沿杂志:电子版, 2022, 14(4): 1-6, 69.
[10] Introduction: Standards of Medical Care in Diabetes-2018 [J]. Diabetes Care, 2018, 41(Suppl 1): S1-S2.
[11] Fats and fatty acids in human nutrition. Report of an expert consultation [R]. FAO Food Nutr Pap, 2010, 91: 1-166.
[12] KNOWLER W C, BARRETT-CONNOR E, FOWLER S E, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002, 346(6): 393-403.
[13] YKI-JÄRVINEN H. Thiazolidinediones [J]. N Engl J Med, 2004, 351(11): 1106-1118.
[14] DEFRONZO R A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 [J]. Diabetologia, 2010, 53(7): 1270-1287.
[15] BISCHOFF H. The mechanism of alpha-glucosidase inhibition in the management of diabetes [J]. Clin Invest Med, 1995, 18(4): 303-311.
[16] CHIASSON J L, JOSSE R G, GOMIS R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial [J]. JAMA, 2003, 290(4): 486-494.
[17] SHIMABUKURO M, TANAKA A, SATA M, et al. α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study [J]. Cardiovasc Diabetol, 2017, 16(1): 86.
[18] MAHAFFEY K W, NEAL B, PERKOVIC V, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study) [J]. Circulation, 2018, 137(4): 323-334.
[19] FEDEWA M V, GIST N H, EVANS E M, et al. Exercise and insulin resistance in youth: a meta-analysis [J]. Pediatrics, 2014, 133(1): e163-e174.
[20] THORP A A, KINGWELL B A, SETHI P, et al. Alternating bouts of sitting and standing attenuate postprandial glucose responses [J]. Med Sci Sports Exerc, 2014, 46(11): 2053-2061.
[21] American Diabetes Association Professional Practice Committee. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022 [J]. Diabetes Care, 2022, 45(Suppl 1): S39-S45.
[22] JIANG L, JOHNSON A, PRATTE K, et al. Long-term outcomes of lifestyle intervention to prevent diabetes in American Indian and Alaska Native communities: The Special Diabetes Program for Indians Diabetes Prevention Program [J]. Diabetes Care, 2018, 41(7): 1462-1470.
[23] HAMMAN R F, WING R R, EDELSTEIN S L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes [J]. Diabetes Care, 2006, 29(9): 2102-2107.
[24] 赵林雪. 糖尿病健康管理模式的研究进展 [J]. 中国城乡企业卫生, 2020, 35(1): 40-422.
[25] 李锐, 施亮, 杨群娣, 等. 上海市社区管理2型糖尿病患者血糖控制和用药情况 [J]. 环境与职业医学, 2016, 33(4): 329-333.
[26] 侯春梅. 全科医学治疗在2型糖尿病患者疾病治疗过程中的效果研究[J]. 实用糖尿病杂志, 2019, 15(4): 24.
[27] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [J]. Lancet, 1998, 352(9131): 837-853.
[28] NATHAN D M, GENUTH S, LACHIN J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J]. N Engl J Med, 1993, 329(14): 977-986.
[29] NATHAN D M, CLEARY P A, BACKLUND J Y, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [J]. N Engl J Med, 2005, 353(25): 2643-2653.

老年糖尿病医防融合的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	王苏, 赵一璟, 魏晨敏, 陈堃, 曹雯, 王昆, 杨昱. 老年T2DM病人甘油三酯葡萄糖指数与低密度脂蛋白亚型的关系研究[J]. 实用老年医学, 2024, 38(10): 1002-1006.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	周潇, 顾荣, 孔小岑, 罗勇, 王蔚萍, 马建华, 李惠琴. 桑枝总生物碱和卡格列净治疗血糖控制不佳的老年2型糖尿病病人的疗效观察[J]. 实用老年医学, 2024, 38(10): 1066-1069.
[4]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[5]	刘童君, 赵雅洁, 胡洁玲, 胡洋, 梁伟. 糖代谢异常对血清激活素A水平的影响[J]. 实用老年医学, 2024, 38(5): 495-437.
[6]	杨龙璇, 唐伟. 细胞衰老与2型糖尿病胰岛B细胞功能障碍的研究进展[J]. 实用老年医学, 2024, 38(5): 521-437.
[7]	王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437.
[8]	唐源, 邓暑芳, 何咏梅, 戴雨璇, 罗晶. 老年2型糖尿病病人健康素养水平及其与衰弱的相关性[J]. 实用老年医学, 2024, 38(3): 255-259.
[9]	代玲俐, 俞匀. 老年2型糖尿病病人估计肾小球滤过率与胰岛素抵抗及胰岛B细胞功能的相关性研究[J]. 实用老年医学, 2023, 37(12): 1219-1223.
[10]	范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237.
[11]	张贺成, 魏苏. 老年2型糖尿病病人血清铁蛋白水平与糖尿病足发生的相关性[J]. 实用老年医学, 2023, 37(11): 1111-1114.
[12]	胡艳, 巫海娣, 王雪菲, 娄青林, 叶青, 顾刘宝, 戴静, 宋小波. 老年2型糖尿病病人糖尿病足风险评分与尿微量白蛋白/肌酐的相关性分析[J]. 实用老年医学, 2023, 37(11): 1134-1137.
[13]	宗前兴, 莫永珍. 老年2型糖尿病健康状态分层框架的应用与研究进展[J]. 实用老年医学, 2023, 37(11): 1170-1175.
[14]	张林英, 梅群超, 张炜琦, 胡一兰. 抗阻训练联合高乳蛋白营养在老年2型糖尿病伴肌少症病人中的应用研究[J]. 实用老年医学, 2023, 37(10): 995-999.
[15]	刘倩慧, 姚子俊, 何玉立, 吴军. SGLT2i对老年糖尿病病人心血管保护机制的研究进展[J]. 实用老年医学, 2023, 37(10): 1064-1068.